Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: Further support for its efficacy

Clinical and Experimental Dermatology

Volumn 23, Issue 6, 1998, Pages 254-257

  Reiche, L ^a   Wojnarowska, F ^b   Mallon, E ^b  

^a AMERSHAM HOSPITAL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; NICOTINAMIDE; TETRACYCLINE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CHRONOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEADACHE; HUMAN; HYPERPIGMENTATION; MALE; MUCOUS MEMBRANE PEMPHIGOID; NAUSEA; PRIORITY JOURNAL;

EID: 0032422653     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1998.00379.x     Document Type: Article

References (25)

1. 1. Nayar M, Wojnarowska F, Venning V et al. Association of autoimmunity and cicatricial pemphigoid: Is there an immunogenetic basis? J Am Acad Dermatol 1991; 25: 1011-5.
2. 2. Nayar M, Wojnarowska F. Cicatricial pemphigoid: a re evaluation of therapy. J Dermatol Treat 1993; 4: 89-93.
3. 3. Poskitt L, Wojnarowska F. Drug treatment of autoimmune blistering diseases. In: Marks R, Cunliffe WJ, eds. Skin Therapy. London: Martin Dunitz Publications, 1994: 184-90.
4. 4. Wolverton SE. Monitoring for adverse effects from systemic drugs used in dermatology. J Am Acad Dermatol 1992; 26: 661-79.
5. 5. McDonald GJ. Use of cytotoxic drugs in dermatologic diseases IL J Am Acad Dermatol 1985; 6: 965-75.
6. 6. Poskitt L, Wojnarowska F. Minimising cicatricial pemphigoid orodynia with minocycline. Br J Dermatol 1995; 132: 784-9.
7. 7. Berk M, Lorinez AL. The treatment of bullous pemphigoid with tetracycline and niacinamide. Arch Dermatol 1986; 122: 670-4.
8. 8. Fivenson D, Breneman D, Rosen G et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994; 130: 753-8.
9. 9. Kolbach DN, Remme JJ, Bos WH et al. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 1995; 133: 88-90.
10. 10. Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nocotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol 1993; 28: 998-1000.
11. 11. Mallon E, Wojnarowska F. Cicatricial pemphigoid presenting with unusual palmar involvement, successfully treated with a combination of nicotinamide and tetracycline. Clin Exp Dermatol 1994; 19: 526-30.
12. 12. Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin Exp Dermatol 1995, 20: 258-9.
13. 13. Wolverton SE, Wilkin JK. New uses for old drugs. In: Wolverton SE, Wilkin JK eds. Systemic Drugs for Skin Diseases. Philadelphia: W.B. Saunders 1991: 373-4.
14. 14. Burger DR, Vandenbark AA, Daves D et al. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. J Immunol 1976; 117: 797-801.
15. 15. Johnson HH, Binkley GW. Nicotinic acid therapy of dermatitis herpetiformis. J Invest Dermatol 1950; 14: 233-8.
16. 16. Kohler IK, Lorinez AL. Erythema elevatum diutinum treated with niacinamide and tetracycline. Arch Dermatol 1980; 116: 693-5.
17. 17. Ma M, Medenica M. Response of generalised granuloma annulare to high dose niacinamide. Arch Dermatol 1983; 119: 836-9.
18. 18. Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol 1986; 115: 77-80.
19. 19. Handfield-Jones S, Jones S, Peachey R. High dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol 1988; 118: 693-6.
20. 20. Belle M. Halpern MM. Oral nicotinic acid for hyperlipemia-with emphasis on side effects. Am J Cardiol 1958; 2: 449-52.
21. 21. Berge KG, Achor RWP, Christensen NA et al. Hypercholester emia and nicotinic acid: a long term study. Am J Med 1961; 31: 24-36.
22. 22. Gurian H, Aldersberg D. The effect of large doses of nicotinic acid on circulating lipids and carbohydrate tolerance. Am J Med Sci 1959; 237: 12-22.
23. 23. Kohn RM, Montes M. Hepatic fibrosis following long acting nicotinic acid therapy: a case report. Am J Med Sci 1969; 258: 94-9.
24. 24. Pardue WO. Severe liver dysfunction during nicotinic acid therapy. J Am Med Assoc 1959; 170: 2088-9.
25. 3 (nicotinamide). N Engl J Med 1973; 289: 1180-2.